MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 341 to 360 of 1,960 approvalsPage 18 of 98

Uplizna

Authorisation: Apr 25, 2022

PreHevbri

Authorisation: Apr 25, 2022

Sitagliptin Accord

Authorisation: Apr 25, 2022

Vydura

Authorisation: Apr 25, 2022

Truvelog Mix 30

Authorisation: Apr 25, 2022

Padcev

Authorisation: Apr 13, 2022

Padcev

Authorisation: Apr 13, 2022

Kimmtrak

Authorisation: Apr 1, 2022

Stimufend

Authorisation: Mar 28, 2022

Evusheld

Authorisation: Mar 25, 2022

Sondelbay

Authorisation: Mar 24, 2022

Sondelbay

Authorisation: Mar 24, 2022

Ontilyv

Authorisation: Feb 21, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.